These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8968341

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of type IV phosphodiesterase by Ro 20-1724 attenuates endotoxin-induced acute renal failure.
    Begany DP, Carcillo JA, Herzer WA, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 1996 Jul; 278(1):37-41. PubMed ID: 8764333
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of the type IV phosphodiesterase inhibitor Ro 20-1724 on catecholamine-induced alterations in regional vascular resistance and regional blood flow.
    Thomas NJ, Herzer WA, Carcillo JA, Jackson EK.
    J Cardiovasc Pharmacol; 1998 Jun; 31(6):840-53. PubMed ID: 9641468
    [Abstract] [Full Text] [Related]

  • 8. Type IV phosphodiesterase inhibition improves cardiac contractility in endotoxemic rats.
    Thomas NJ, Carcillo JA, Herzer WA, Mi Z, Tofovic SP, Jackson EK.
    Eur J Pharmacol; 2003 Mar 28; 465(1-2):133-9. PubMed ID: 12650842
    [Abstract] [Full Text] [Related]

  • 9. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG, Thiemermann C.
    Br J Pharmacol; 1997 Aug 28; 121(8):1824-30. PubMed ID: 9283724
    [Abstract] [Full Text] [Related]

  • 10. N-Allylsecoboldine as a novel agent prevents acute renal failure during endotoxemia.
    Chiao CW, Lee SS, Wu CC, Su MJ.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):291-300. PubMed ID: 16545365
    [Abstract] [Full Text] [Related]

  • 11. Aminoguanidine attenuates endotoxin-induced mesenteric vascular hyporeactivity.
    Kavuklu B, Iskit AB, Guc MO, Ilhan M, Sayek I.
    Br J Surg; 2000 Apr 27; 87(4):448-53. PubMed ID: 10759741
    [Abstract] [Full Text] [Related]

  • 12. Reversal of acute tacrolimus-induced renal vasoconstriction by theophylline in rats.
    McLaughlin GE, Kashimawo LA, Steele BW, Kuluz JW.
    Pediatr Crit Care Med; 2003 Jul 27; 4(3):358-62. PubMed ID: 12831420
    [Abstract] [Full Text] [Related]

  • 13. Effects of sarafotoxin S6c on antidiuresis and norepinephrine overflow induced by stimulation of renal nerves in anesthetized dogs.
    Matsuo G, Matsumura Y, Tadano K, Morimoto S.
    J Pharmacol Exp Ther; 1997 Feb 27; 280(2):905-10. PubMed ID: 9023305
    [Abstract] [Full Text] [Related]

  • 14. Comparative effects of early versus delayed use of norepinephrine in resuscitated endotoxic shock.
    Sennoun N, Montemont C, Gibot S, Lacolley P, Levy B.
    Crit Care Med; 2007 Jul 27; 35(7):1736-40. PubMed ID: 17522580
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.